Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Hydrochloride Ear Drops Phase IV Safety Study
CTR20210140Phase 4Completed
- Sponsor
- Shenzhen Wanhe Pharmaceutical
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in external otitis, otitis media, sponsored by Shenzhen Wanhe Pharmaceutical. Started Jan 2021; status: completed.
02
Drugs
levofloxacin
03
Conditions
external otitisotitis media
Beyond the preview
Go deeper on CTR20210140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210140.